Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
Epigenomics
DOI:
10.1007/s00401-023-02640-7
Publication Date:
2023-10-18T13:02:10Z
AUTHORS (30)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (6)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....